TMC Life Sciences Berhad (0101.KL)
MYR 0.48
(4.35%)
MYR 0.48
(4.35%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 90.78 Million MYR | 10.24% |
| 2022 | 76.3 Million MYR | 51.48% |
| 2021 | 50.13 Million MYR | 21.58% |
| 2020 | 41.13 Million MYR | 43.11% |
| 2019 | 28.6 Million MYR | -42.15% |
| 2018 | 49.44 Million MYR | 7.63% |
| 2017 | 46.06 Million MYR | 19.4% |
| 2016 | 38.47 Million MYR | 28.6% |
| 2015 | 29.91 Million MYR | 76.35% |
| 2014 | 16.96 Million MYR | 15.11% |
| 2013 | 14.73 Million MYR | 48.81% |
| 2012 | 9.88 Million MYR | 154.9% |
| 2011 | 5.9 Million MYR | 119.39% |
| 2010 | -20.13 Million MYR | -3292.13% |
| 2009 | 627.51 Thousand MYR | -89.99% |
| 2008 | 6.26 Million MYR | -57.19% |
| 2007 | 14.64 Million MYR | 6.87% |
| 2006 | 13.7 Million MYR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q4 | 9.05 Million MYR | -55.96% |
| 2023 FY | - MYR | 10.24% |
| 2023 Q1 | 29.51 Million MYR | 36.22% |
| 2023 Q2 | 27.47 Million MYR | -6.91% |
| 2023 Q3 | 20.56 Million MYR | -25.16% |
| 2022 Q1 | 17.02 Million MYR | -6.09% |
| 2022 Q3 | 21.16 Million MYR | 28.69% |
| 2022 Q4 | 21.66 Million MYR | 2.37% |
| 2022 FY | - MYR | 51.48% |
| 2022 Q2 | 16.44 Million MYR | -3.41% |
| 2021 Q3 | 11.07 Million MYR | -8.38% |
| 2021 FY | - MYR | 21.58% |
| 2021 Q4 | 18.13 Million MYR | 63.71% |
| 2021 Q1 | 8.84 Million MYR | -2.9% |
| 2021 Q2 | 12.08 Million MYR | 36.71% |
| 2020 Q1 | 13.8 Million MYR | 0.0% |
| 2020 Q2 | 10.33 Million MYR | -25.14% |
| 2020 Q4 | 9.1 Million MYR | 15.46% |
| 2020 FY | - MYR | 43.11% |
| 2020 Q3 | 7.88 Million MYR | -23.69% |
| 2019 FY | - MYR | -42.15% |
| 2019 Q1 | 12.14 Million MYR | -9.56% |
| 2019 Q3 | 12.12 Million MYR | -13.01% |
| 2019 Q2 | 13.94 Million MYR | 14.78% |
| 2018 Q1 | 10.39 Million MYR | -7.6% |
| 2018 Q3 | 11.09 Million MYR | -13.09% |
| 2018 Q4 | 13.43 Million MYR | 21.05% |
| 2018 FY | - MYR | 7.63% |
| 2018 Q2 | 12.76 Million MYR | 22.82% |
| 2017 Q1 | 6.76 Million MYR | -39.19% |
| 2017 FY | - MYR | 19.4% |
| 2017 Q3 | 9.6 Million MYR | -15.57% |
| 2017 Q2 | 11.37 Million MYR | 68.09% |
| 2017 Q4 | 11.25 Million MYR | 17.11% |
| 2016 FY | - MYR | 28.6% |
| 2016 Q1 | 7.89 Million MYR | -10.81% |
| 2016 Q2 | 8.57 Million MYR | 8.64% |
| 2016 Q3 | 9.07 Million MYR | 5.86% |
| 2016 Q4 | 11.13 Million MYR | 22.68% |
| 2015 Q4 | 8.84 Million MYR | 22.5% |
| 2015 Q2 | 7.22 Million MYR | 8.95% |
| 2015 Q3 | 7.22 Million MYR | 0.0% |
| 2015 FY | - MYR | 76.35% |
| 2015 Q1 | 6.62 Million MYR | 35.49% |
| 2014 FY | - MYR | 15.11% |
| 2014 Q4 | 4.89 Million MYR | 27.13% |
| 2014 Q3 | 3.84 Million MYR | -1.21% |
| 2014 Q2 | 3.89 Million MYR | 63.04% |
| 2014 Q1 | 2.38 Million MYR | -29.59% |
| 2013 Q1 | 1.68 Million MYR | 50.13% |
| 2013 Q2 | 4.32 Million MYR | 157.26% |
| 2013 Q3 | 3.52 Million MYR | -18.39% |
| 2013 FY | - MYR | 48.81% |
| 2013 Q4 | 3.39 Million MYR | -3.8% |
| 2012 Q2 | 2.65 Million MYR | 28.98% |
| 2012 Q1 | 2.06 Million MYR | 362.42% |
| 2012 FY | - MYR | 154.9% |
| 2012 Q4 | 1.11 Million MYR | -45.86% |
| 2012 Q3 | 2.06 Million MYR | -22.21% |
| 2011 Q2 | -420 Thousand MYR | -164.52% |
| 2011 Q3 | 1.32 Million MYR | 415.95% |
| 2011 Q4 | -785 Thousand MYR | -159.16% |
| 2011 Q1 | 651 Thousand MYR | 0.0% |
| 2011 FY | - MYR | 119.39% |
| 2010 FY | - MYR | -3292.13% |
| 2009 FY | - MYR | -89.99% |
| 2008 FY | - MYR | -57.19% |
| 2007 FY | - MYR | 6.87% |
| 2006 FY | - MYR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| IHH Healthcare Berhad | 6.28 Billion MYR | 98.555% |
| KPJ Healthcare Berhad | 814.46 Million MYR | 88.854% |